Brief: Acadia Pharmaceuticals Q1 EPS USD 0.1 Vs. IBES Estimate USD 0.05
08/05/2024 21:05
May 08 (Reuters) - Acadia Pharmaceuticals Q1 operating expenses USD 190.621 million. * Q1 product sales USD 205.831 million vs. IBES estimate USD 208.3 million * Q1 net income USD 16.555 million vs. IBES estimate USD 9.5 million * Q1 pretax profit USD 21.002 million vs. IBES estimate USD 10.7 million
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry